Related Experiment Video
Updated: Jul 5, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Immune-mediated pathways in chronic inflammatory arthritis.
Claire L Gorman1, Andrew P Cope
1The Kennedy Institute of Rheumatology, Faculty of Medicine, Imperial College, 1 Aspenlea Road, Hammersmith, London W6 8LH, UK. c.gorman@imperial.ac.uk <c.gorman@imperial.ac.uk>
Rheumatoid arthritis (RA) is a chronic inflammatory disease with unknown causes. Recent breakthroughs have significantly improved how RA patients are treated.
Area of Science:
- Immunology
- Rheumatology
- Inflammation
Background:
- Rheumatoid arthritis (RA) is a primary model of chronic inflammatory arthropathy.
- The exact cause of RA remains unknown.
- Significant advancements in understanding RA have emerged recently.
Purpose of the Study:
- To review recent critical advances in the understanding of rheumatoid arthritis.
- To discuss the impact of these advances on patient treatment.
Main Methods:
- Literature review of recent studies on rheumatoid arthritis.
- Analysis of the impact of new findings on clinical practice.
Main Results:
- Key breakthroughs in RA pathogenesis and understanding have been identified.
- These advances have demonstrably improved treatment strategies for RA patients.
Conclusions:
- Recent scientific progress has enhanced the understanding of rheumatoid arthritis.
- This improved knowledge is directly translating into better therapeutic outcomes for individuals with RA.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Chronic Inflammation: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
The JAK-STAT Signaling Pathway
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
